Gogodigital Paypal Donation_en
EQUIVITA, Anti-Vivisection Scientific Association, coordinates doctors and scientists who join the fight against the animal experimentation, because this cruel practice is dangerously leading medical research in the wrong direction.
EQUIVITA carries on for more than 10 years a continuative and important actionin against any improper use of genetic modifications, against the diffusion of any kind of OGM and finally against patents on life.
17 maggio 2013: centenario della nascita di Hans Ruesch, padre del
movimento antivivisezionista scientifico in Italia.
Il 17 maggio entrante, nella Biblioteca Sormani di Milano, verrà celebrata dalla “Fondazione Hans Ruesch per una medicina senza vivisezione” la ricorrenza del 1° centenario della nascita di Hans Ruesch, scrittore di fama internazionale, ma soprattutto precursore, con il saggio “Imperatrice nuda”, di un nuovo pensiero scientifico, alla cui diffusione ha dedicato gli ultimi 40 anni di vita.
Hans Ruesch con “Imperatrice Nuda” e numerosi altri libri che hanno fatto seguito, ha denunciato l’errore scientifico insito nel “modello animale” per la ricerca biomedica, lanciando l’accusa di “incompetenza, vanità, insensibilità, sadismo, stupidità” alla pratica della vivisezione, sollevando violente polemiche per i segreti che svelava e gli interessi che colpiva. Oggi questi interessi hanno il destino segnato, grazie alle numerose e prestigiose istituzioni scientifiche che hanno visto la necessità di un un cambiamento verso un nuovo paradigma scientifico, quello che rinnega la validità dei test su animali.
Per noi del “Fondo Imperatrice Nuda contro la Sperimentazione Animale”, il cui organo operativo è il Comitato Scientifico EQUIVITA la celebrazione del centenario della nascita di Hans Ruesch, nostro primo ed insostituibile maestro e decennale Presidente Onorario, ha un valore prezioso, dal momento che tutta la nostra attività si è ispirata ai suoi insegnamenti e dal momento che oggi stiamo infine per vedersi avverare la fine della sperimentazione animale.
Qui la presentazione dell'iniziativa di Milano
EQUIVITA, Comitato Scientifico Antivivisezionista
Via P. A. Micheli, 62 00197 Roma
Tel. +39.06.3220720, Cell. 335.8444949, Fax +39.06.3225370
emailto: firstname.lastname@example.org www.equivita.it;
Per donazioni: c/c postale:88922000 oppure, IBAN: IT55 N076 0103 2000 00088922000
EQUIVITA PRESS RELEASE 26/02/2012
900 MONKEYS FOR FAKE SCIENCE
900 monkeys for experimentation are arriving in Italy from China
Following the news that 900 monkeys to be used for experimentation are arriving in Italy from China, EQUIVITA Scientific Commission believes that the time has come to say
- Stop passing off as valid a research method which has NEVER undergone (and would never pass) the verification process imposed to any other method.
- Stop imposing on Europe a biomedical research method which is considered anti-scientific, and therefore misleading, by an increasingly wide number of scientists and by the most qualified scientific centres (see the papers published on Science, British Medical Journal, Scientific American, Nature, etc.), since the responses obtained from animals cannot be transferred to the human species.
Open letter to the Minister of Health, Mr Renato Balduzzi, on the transposition of the EU Directive 2010/63/EU (vivisection):
Rome, 9th January, 2012
The EU Directive 2010/63/EU, which is now in the transposition period in our Country, has been approved in Strasbourg ignoring two important contradictory opinion :
comes from a significant number of physicians and scientists, who claim the scientific invalidity of animal testing and the damage caused by the extrapolation of data from one species to another, particularly from animals to humans.Such an erroneous method represents:
an obstacle to scientific progress that mainly involves Europe, which cannot keep up with new discoveries, essential for the safeguard of human health and pursued somewhere else with a quite different approach.For example, since 2007, the American National Research Council declared that an 'epochal turning-point' in toxicological tests was necessary to surpass the animal models and, in that direction, it started a five-year research plan, which was signed by the most important USA control agencies;
a huge waste of money.As Robert Weinberg, Biology Professor at MIT said, "every year, pharmaceutical industries waste hundreds of millions dollars using rodents as models in oncology research";
an even more serious waste of human lives.In 2007, 197,000 people died because of adverse reactions to drugs in the EU only; a misleading research method like animal testing certainly contributed to this tragedy.
comes from the common feeling of the great majority of citizens, who believe in the rights of animals as sentient beings (Treaty of Lisbon, Art. 13).This is testified by the 120,000 signatures collected in Italy in just two months, in summer 2010, against the Directive, which has been improperly named "Law for the protection of animals used for scientific purposes".As a matter of fact, no protection is granted to animals under this law, which seems to come from the dark centuries of our history.
A noisy silence - EPO’s reply to civil society’s accusations
Last week, in spite of uninterrupted rain, over 300 million protesters gathered in Munich to voice their refusal of EPO’s patent policy. The large crowd included a wide range of environment activists, farmers and development organizations from several European countries.
Just outside the main entrance to the majestic building owned by EPO (European Patent Office), the protesters reported the irregularities found in the latest patents granted on living matter (which represents the most precious common good). Such patents even exceed the rather loose limitations imposed by European laws.
In fact, not only do they concern plants and animals reproduced through biotechnological processes, but also those reproduced through ‘essentially biological methods’, which do not need to be patented according to the European Patent Convention or to the Directive 98/44 named ‘Directive for the protection of biotechnological inventions’.
Following an appeal filed against the patent on broccoli (EP1069819), it was decided that such a plant would represent a ‘judicial case’ for EPO and that, based on the decision of the High Court of Appeal (the EPO’s inner court), it should be decided whether patents should also be granted on plants reproduced through conventional methods.